Sweet and sticky: diabetic platelets, enhanced reactivity, and cardiovascular risk.
Simon
Daniel I
DI
Schmaier
Alvin H
AH
D000789:Angina, Unstable / Q000097:blood / Q000503:physiopathology; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000502:physiology; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000097:blood* / Q000188:drug therapy; D016757:Death, Sudden, Cardiac; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000503:physiopathology; D015539:Platelet Activation / Q000502:physiology*; D010974:Platelet Aggregation / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D020521:Stroke / Q000097:blood / Q000503:physiopathology; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin